Renalytix partners with Tempus AI to expand kidney disease testing
Go back to Renalytix partners with Tempus AI to expand kidney disease testing| Oppenheimer Real Estate Fund Class N (NASDAQ: RENX) | Delayed: 1.67 -0.05 (2.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.72 | 52 Week High | $18.34 | |||
| Open | $1.69 | 52 Week Low | $14.92 | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.67 | EPS | $0.00 | |||
| Volume | 47,966 | |||||
| (AMEX: RNLXY) | Delayed: 1.21 +0.03 (2.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.18 | 52 Week High | $ | |||
| Open | $1.11 | 52 Week Low | $ | |||
| Day High | $1.21 | P/E | N/A | |||
| Day Low | $1.11 | EPS | $ | |||
| Volume | 2,441 | |||||
| StemCells, Inc. (NASDAQ: TEM) | Delayed: 48.61 +0.76 (1.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.85 | 52 Week High | $0.45 | |||
| Open | $47.00 | 52 Week Low | $0.37 | |||
| Day High | $49.85 | P/E | N/A | |||
| Day Low | $46.68 | EPS | $-0.31 | |||
| Volume | 5,325,349 | |||||

